Author:
Oe Ai,Kawabe Joji,Torii Kenji,Kawamura Etsushi,Kotani Jin,Hayashi Takehiro,Kurooka Hiroko,Tsumoto Chikako,Higashiyama Shigeaki,Kusuki Makoto,Tsushima Hiroyuki,Yamane Hideo,Shiomi Susumu
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,General Medicine
Reference23 articles.
1. Van den Abbeele AD, Badawi RD. Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs).Eur J Cancer 2002; 38 (Suppl 5): S60–65.
2. Kitagawa Y, Nishizawa S, Sano K, Ogasawara T, Nakamura M, Sadato N, et al. Prospective comparison of18F-FDG PET with conventional imaging modalities (MRI, CT, and67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.J Nucl Med 2003; 44: 198–206.
3. Sakamoto H, Nakai Y, Ohashi Y, Matsuda M, Sakashita T, Nasako Y, et al. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas.Acta Otolaryngol 1998; 538 (Suppl): 254–260.
4. Kubota K, Yokoyama J, Yamaguchi K, Ono S, Qureshy A, Itoh M, et al. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.Eur J Nucl Med Mol Imaging 2004; 31: 590–595.
5. Kubota K. From tumor biology to clinical PET: A review of positron emission tomography (PET) in oncology.Ann Nucl Med 2001; 15: 471–486.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献